{
  "catalogId": "f6cc48fb-89a5-47d4-a9c1-13a7adcc78ec",
  "name": "INREBIC",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "168 28 36598 99",
  "treatmentDescriptions": "INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF)",
  "termsOfIssue": "Prescription required",
  "form": "capsules",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "FEDRATINIB AS DIHYDROCHLORIDE MONOHYDRATE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE57",
      "name": "FEDRATINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "INREBIC 100 MG 120 CAPS",
      "manufacturer": {
        "name": "ב.מ.ס",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 120.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "8773",
        "yarpa": "84739",
        "barcode": "7290014396173"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 13388.32123,
        "retailMargin": 10.0,
        "maxRetailPrice": 14727.15335,
        "maxPriceWithVAT": 17378.04018
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.684114"
  }
}